GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzolytics Inc (OTCPK:ENZC) » Definitions » PS Ratio

Enzolytics (Enzolytics) PS Ratio : 0.00 (As of May. 02, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Enzolytics PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Enzolytics's share price is $0.0053. Enzolytics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2011 was $1.82. Hence, Enzolytics's PS Ratio for today is 0.00.

The historical rank and industry rank for Enzolytics's PS Ratio or its related term are showing as below:

ENZC's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 9.095
* Ranked among companies with meaningful PS Ratio only.

Enzolytics's Revenue per Sharefor the three months ended in Jun. 2011 was $0.39. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2011 was $1.82.

Back to Basics: PS Ratio


Enzolytics PS Ratio Historical Data

The historical data trend for Enzolytics's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzolytics PS Ratio Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
PS Ratio
- - 257.14 45.59

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.72 90.25 45.59 - -

Competitive Comparison of Enzolytics's PS Ratio

For the Biotechnology subindustry, Enzolytics's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzolytics's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzolytics's PS Ratio distribution charts can be found below:

* The bar in red indicates where Enzolytics's PS Ratio falls into.



Enzolytics PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Enzolytics's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0053/1.816
=0.00

Enzolytics's Share Price of today is $0.0053.
Enzolytics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.82.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Enzolytics  (OTCPK:ENZC) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Enzolytics PS Ratio Related Terms

Thank you for viewing the detailed overview of Enzolytics's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzolytics (Enzolytics) Business Description

Traded in Other Exchanges
N/A
Address
1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.

Enzolytics (Enzolytics) Headlines

From GuruFocus

Enzolytics, Inc. Announces New Advisory Board Member

By ACCESSWIRE ACCESSWIRE 10-24-2022